These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 472728)

  • 21. Effects of cholinergic enhancement therapies on memory function in Alzheimer's disease: a meta-analysis of the literature.
    Jorm AF
    Aust N Z J Psychiatry; 1986 Jun; 20(2):237-40. PubMed ID: 3464268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Memory problems in dementia: adaptation and coping strategies and psychosocial treatments.
    Dröes RM; van der Roest HG; van Mierlo L; Meiland FJ
    Expert Rev Neurother; 2011 Dec; 11(12):1769-81; quiz 1782. PubMed ID: 22091600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [German-speaking memory clinics: state of the art and practical recommendations].
    Diehl J; Staehelin H; Wiltfang J; Hampel H; Calabrese P; Monsch A; Schmid R; Romero B; Schunk M; Kuhlmann HP; Wolter-Henseler DK; Mauerer C; Stoppe G; Kurz A;
    Z Gerontol Geriatr; 2003 Jun; 36(3):189-96. PubMed ID: 12825136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination therapy with galantamine and memantine improves behavioral and psychological symptoms of dementia (BPSD) in patients with early-onset Alzheimer's disease.
    Hamuro A
    Aust N Z J Psychiatry; 2013 Jun; 47(6):583. PubMed ID: 23093052
    [No Abstract]   [Full Text] [Related]  

  • 25. Memory Impairment, Dementia, and Alzheimer's Disease in Classical and Contemporary Traditional Chinese Medicine.
    May BH; Feng M; Zhou IW; Chang SY; Lu SC; Zhang AL; Guo XF; Lu CJ; Xue CC
    J Altern Complement Med; 2016 Sep; 22(9):695-705. PubMed ID: 27464225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The cholinergic treatment strategy in aging and senile dementia.
    Johns CA; Greenwald BS; Mohs RC; Davis KL
    Psychopharmacol Bull; 1983; 19(2):185-97. PubMed ID: 6346373
    [No Abstract]   [Full Text] [Related]  

  • 27. [Update on current care guidelines. The diagnosis and medical treatment of memory disorders].
    Suhonen J; Pirttilä T; Erkinjuntti T; Koponen H; Makkonen M; Puurunen M; Raivio M; Rinne J; Rosenvall A; Strandberg T; Vanninen R; Vataja R; ; ; ; ;
    Duodecim; 2010; 126(18):2167-8. PubMed ID: 21072963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cholinergic agents in the treatment of Alzheimer's disease].
    Zemishlany Z; Davidson M; Davis KL
    Harefuah; 1987 Dec; 113(12):401-4. PubMed ID: 3330722
    [No Abstract]   [Full Text] [Related]  

  • 29. Long-term administration of oral physostigmine and lecithin improve memory in Alzheimer's disease.
    Levin HS; Peters BH
    Ann Neurol; 1984 Feb; 15(2):210. PubMed ID: 6703661
    [No Abstract]   [Full Text] [Related]  

  • 30. Intracranial drug administration in Alzheimer's disease.
    Harbaugh RE
    Psychopharmacol Bull; 1986; 22(1):106-9. PubMed ID: 3726055
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacologic management of Alzheimer-type dementia.
    Volicer L; Herz LR
    Am Fam Physician; 1985 Jul; 32(1):123-8. PubMed ID: 2861736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The effects of cholinergic preparations in Alzheimer's disease].
    Bradley RJ; Edge MT; Freeman AM
    Farmakol Toksikol; 1991; 54(3):4-10. PubMed ID: 1915820
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacological approaches in the treatment of senile dementia.
    Markstein R
    Eur Neurol; 1989; 29 Suppl 3():33-41. PubMed ID: 2575520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholinergic drugs in Alzheimer's disease.
    Davis KL; Mohs RC
    N Engl J Med; 1986 Nov; 315(20):1286-7. PubMed ID: 3773941
    [No Abstract]   [Full Text] [Related]  

  • 35. A dose-ranging study of lecithin in the treatment of primary degenerative dementia (Alzheimer disease).
    Brinkman SD; Pomara N; Goodnick PJ; Barnett N; Domino EF
    J Clin Psychopharmacol; 1982 Aug; 2(4):281-5. PubMed ID: 7119136
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical aspects of cholinergic pharmacology.
    Hanin I
    Prog Brain Res; 1993; 98():421-2. PubMed ID: 8248530
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment of Alzheimer disease and the main primary degenerative dementias].
    Casacchia M; Pollice R
    Clin Ter; 1999; 150(6):425-37. PubMed ID: 10756663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of Alzheimer's disease with cholinergic drugs.
    Kumar V; Calache M
    Int J Clin Pharmacol Ther Toxicol; 1991 Jan; 29(1):23-37. PubMed ID: 2004862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical effects of choline in Alzheimer senile dementia.
    Boyd WD; Graham-White J; Blackwood G; Glen I; McQueen J
    Lancet; 1977 Oct; 2(8040):711. PubMed ID: 71516
    [No Abstract]   [Full Text] [Related]  

  • 40. Therapeutic strategies in Alzheimer's disease.
    Mayeux R
    Neurology; 1990 Jan; 40(1):175-80. PubMed ID: 1967490
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.